While Tir-2 targets GLP-1 and GIP, Ret-3 adds a third hormone: Glucagon.
|
Factor |
Reported Results (Phase 3 Data) |
|
Weight Loss |
24% to 29% average body weight loss. Destroys white visceral fat, “the silent killer”. |
|
Blood Sugar (A1C) |
Reductions of 1.7% to 2.0% in Type 2 diabetics, potentially outperforming current “gold standard” medications. |
|
Liver Fat |
Unprecedented 82% to 86% reduction in liver fat. Nearly 90% of patients achieved “normal” liver fat levels. |
|
Joint Health |
A 75.8% reduction in pain scores for patients with knee osteoarthritis, likely due to the massive reduction in mechanical load and inflammation. |
|
Metabolic Rate |
Unlike previous peptides, the glucagon component helps prevent the metabolic slowdown typically seen during aggressive weight loss. |




All products sold by APR Labs are for laboratory research use only. Not for human or animal consumption, injection, or medical use. APR Labs does not provide medical advice. By purchasing, you agree that you are a qualified professional and assume all responsibility for handling and use. See our Research Use Disclaimer for full terms.
By clicking ENTER, you confirm that you are 21 or older and understand that all products sold by APR Labs are strictly for research purposes only and NOT for human or animal consumption, or for any medical or therapeutic use.You also agree to comply with all applicable laws and take full responsibility for proper handling and use.
If you do not agree, please click EXIT.